Back to Search
Start Over
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
- Source :
- The Lancet; June 2022, Vol. 399 Issue: 10342 p2212-2225, 14p
- Publication Year :
- 2022
-
Abstract
- Vaccination of children and young people against SARS-CoV-2 is recommended in some countries. Scarce data have been published on immune responses induced by COVID-19 vaccines in people younger than 18 years compared with the same data that are available in adults.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 399
- Issue :
- 10342
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs59902944
- Full Text :
- https://doi.org/10.1016/S0140-6736(22)00770-X